Your browser doesn't support javascript.
loading
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
Lee, Ji Hyun; Park, Yong; Kang, Ka-Won; Lee, Je-Jung; Lee, Ho Sup; Eom, Hyeon-Seok; Do, Young Rok; Kim, Jin Seok; Yoon, Sung-Soo; Shin, Dong-Yeop; Koh, Youngil; Kim, Ki-Hyun; Lee, Won Sik; Jo, Jae-Cheol; Lee, Yoo Jin; Lee, Ji Yun; Kim, Dae Sik; Shim, Hyeok; Chang, Myung Hee; Kim, Sung-Hyun; Min, Chang-Ki.
Afiliación
  • Lee JH; Department of Internal medicine, Dong-A University College of Medicine, 26, Daesingongwon-ro, Seo-gu, Busan, 49201, Republic of Korea.
  • Park Y; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Kang KW; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.
  • Lee HS; Department of Internal Medicine, Kosin University College of Medicine, Busan, Republic of Korea.
  • Eom HS; Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea.
  • Do YR; Division of Hematology-Oncology, School of Medicine, Keimyung University, Daegu, Republic of Korea.
  • Kim JS; Dvision of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Shin DY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Koh Y; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim KH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lee WS; Department of Internal Medicine, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan, Republic of Korea.
  • Jo JC; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
  • Lee YJ; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
  • Lee JY; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim DS; Department of Hematology-Oncology, Korea University College of Medicine, Seoul, Republic of Korea.
  • Shim H; Department of Internal Medicine, Wonkwang University School of Medicine, Gunpo, Republic of Korea.
  • Chang MH; Division of Hematology-Oncology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
  • Kim SH; Department of Internal medicine, Dong-A University College of Medicine, 26, Daesingongwon-ro, Seo-gu, Busan, 49201, Republic of Korea. kshmoon@dau.ac.kr.
  • Min CK; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. ckmin@catholic.ac.kr.
Ann Hematol ; 100(8): 2051-2059, 2021 Aug.
Article en En | MEDLINE | ID: mdl-33447888
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Lenalidomida / Mieloma Múltiple Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Lenalidomida / Mieloma Múltiple Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article